<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "methotrexate inj VIAL">
<dose><value>10 - 25</value>
<value>50</value>
<value>15 - 20</value>
</dose>
<route><value>IM</value>
<value>IV</value>
<value>SC</value>
</route>
<strength><value>25 mg/mL</value>
</strength>
<frequency><value>WEEKLY</value>
<value>ONCE</value>
</frequency>
<instruction></instruction>
<volume><value>2 mL</value>
</volume>
<units><value>mg</value>
<value>mg/m2</value>
</units>
<Population><value>ADULT</value>
<value>INFANT / CHILDREN</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Psoriasis</value>
<value>Ectopic Pregnancy. Recommend if no decline in hCG levels between days 4 and 7, administer a second dose.</value>
<value>Dermatomyositis</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3422</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>